Coverage
-
July 19, 2016
A Washington, D.C., federal judge on Tuesday rejected AstraZeneca's bid for a temporary restraining order in its suit against the U.S. Food and Drug Administration and many generic drug companies seeking to block generic versions of its cholesterol medication Crestor from hitting the market.
2 other articles on this case.
View all »